HIF2A partial gain-of-function (hypermorphic) mutations are associated with erythrocytosis and pulmonary hypertension in humans and in mice (Gale et al. 2008; Percy et al. 2008; Tan et al. 2013). The gene discussed is EPAS1; the disease is pulmonary arterial hypertension.